双胎输血综合征合并重度受血儿心肌病的羊水microRNA谱
本研究比较双胎输血综合征(TTTS)合并重度受血儿心肌病与心脏功能保留者的羊水microRNA表达。14例重度心肌病与12例对照的羊水中110个microRNA被检测,20个差异表达且均下调,前3位为hsa-miR-200c-3p、hsa-miR-17-5p和hsa-miR-539-5p,聚类分析可区分两组,ROC曲线灵敏度和特异度均为80.8%。
要点
- TTTS合并重度受血儿心肌病者羊水20个microRNA均下调。
- 前3位差异microRNA为hsa-miR-200c-3p、hsa-miR-17-5p、hsa-miR-539-5p。
- 基于前3位microRNA的ROC曲线灵敏度和特异度均为80.8%。
核心结论
- TTTS受血儿合并重度心肌病与心脏功能保留者羊水microRNA表达存在差异,提示其可能作为疾病严重程度的生物标志物。
研究设计与样本
- 在羊水减量或选择性胎儿镜激光凝固术时采集单绒毛膜双羊膜囊双胎TTTS羊水,所有胎儿术前超声心动图评估,重度心肌病定义为受血儿右心室心肌性能指数>4 Z-score。
- 共纳入14例重度心肌病和12例心脏功能保留的TTTS对照,羊水microRNA用TaqMan Open Array面板检测379个microRNA。
主要发现
- 羊水中检测到110个microRNA,其中20个差异表达,且均在重度心肌病组下调。
- 区分两组的前3位microRNA为hsa-miR-200c-3p、hsa-miR-17-5p和hsa-miR-539-5p,层次聚类分析显示能较好区分两组。
- 基于前3位microRNA的ROC曲线显示灵敏度和特异度均为80.8%。
关键数值与推荐
- 重度心肌病定义:受血儿右心室心肌性能指数>4 Z-score。
- 前3位microRNA区分两组的灵敏度和特异度均为80.8%。
临床怎么用
- 羊水microRNA有潜力辅助识别TTTS中重度受血儿心肌病高风险妊娠,但尚未进入临床常规。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Twin-twin transfusion syndrome presents many challenges for clinicians, and the optimal means of identifying pregnancies that will benefit most from intervention is controversial. There is currently no clinically available biomarker to detect twin-twin transfusion syndrome or to stratify cases based on the risk factors. microRNAs are small RNAs that regulate gene expression and are biomarkers for various disease processes, including adult and pediatric heart failure. To date, no studies have investigated amniotic fluid microRNAs as biomarkers for disease severity, specifically for severe recipient cardiomyopathy in twin-twin transfusion syndrome cases. OBJECTIVE: This study aimed to assess whether amniotic fluid microRNAs could be useful as biomarkers to identify pregnancies at greatest risk for severe recipient cardiomyopathy associated with twin-twin transfusion syndrome. STUDY DESIGN: Amniotic fluid was collected at the time of amnioreduction or selective fetoscopic laser photocoagulation from monochorionic diamniotic twin pregnancies with twin-twin transfusion syndrome at any stage. Fetal echocardiography was performed on all twins before the procedure, and severe cardiomyopathy was defined as a right ventricular myocardial performance index of the recipient fetus of >4 Z-scores. microRNA was extracted from the amniotic fluid samples and analyzed using an array panel assessing 379 microRNAs (TaqMan Open Array, ThermoFisher). Student t tests were performed to determine significant differences in microRNA expression between pregnancies with severe recipient cardiomyopathy and those with preserved cardiac function. A stringent q value of <.0025 was used to determine differential microRNA expression. Random forest plots identified the top 3 microRNAs that separated the 2 groups, and hierarchical cluster analysis was used to determine if these microRNAs properly segregated the samples according to their clinical groups. RESULTS: A total of 14 amniotic fluid samples from pregnancies with twin-twin transfusion syndrome with severe cardiomyopathy were compared with samples from 12 twin-twin transfusion syndrome control cases with preserved cardiac function. A total of 110 microRNAs were identified in the amniotic fluid samples. Twenty microRNAs were differentially expressed, and the top 3 differentiating microRNAs were hsa-miR-200c-3p, hsa-miR-17-5p, and hsa-miR-539-5p. Hierarchical cluster analysis based on these top 3 microRNAs showed a strong ability to differentiate severe cardiomyopathy cases from controls. The top 3 microRNAs were used to investigate the sensitivity and specificity of these microRNAs to differentiate between the 2 groups with a receiver operating characteristic curve demonstrating sensitivity and specificity of 80.8%. All 20 differentially expressed microRNAs were down-regulated in the group with severe cardiomyopathy. CONCLUSION: Amniotic fluid microRNAs demonstrated differential expression between twin-twin transfusion syndrome recipient fetuses with severe cardiomyopathy and those without and have the potential to be important biomarkers of disease severity in this population.
引用
- Willner EC, Galan HL, Cuneo BF, et al. Amniotic fluid microRNA profiles in twin-twin transfusion syndrome with and without severe recipient cardiomyopathy. Am J Obstet Gynecol. 2021. PMID: 34153234. doi:10.1016/j.ajog.2021.06.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。